Overlooked issues of snakebite management: Time for strategic approach

Current Topics in Medicinal Chemistry

Volumn 11, Issue 20, 2011, Pages 2494-2508

  Girish, K S ^a   Kemparaju, K ^a  

^a UNIVERSITY OF MYSORE   (India)

Author keywords

Antivenom; ECM; Hyaluronidase; Local effects; Snake venom; SVMPs

Indexed keywords

SNAKE VENOM; SNAKE VENOM ANTISERUM;

ACUTE PANCREATITIS; AFRICA; AGRICULTURAL WORKER; ARTHRITIS; ASIA; BRAIN INFARCTION; DIABETES INSIPIDUS; HUMAN; HYPOPHYSIS DISEASE; INCIDENCE; INFERTILITY; KIDNEY FAILURE; MEDICINAL PLANT; MORTALITY; NONHUMAN; OSTEOMYELITIS; REVIEW; SNAKE; SNAKEBITE; SOUTH AND CENTRAL AMERICA; WORLD HEALTH ORGANIZATION;

EID: 80054090027     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/156802611797633393     Document Type: Review

References (158)

1. Chippaux, J. P. Snake-bites: appraisal of the global situation. Bull. World Health Organ., 1998, 75, 515-524.
2. Kasturiratne, A.; Wickremasinghe, A. R.; de Silva N.; Gunawardena, N. K.; Pathmeswaran, A.; Premaratna, R.; Savioli, L.; Lalloo, D. G.; de Silva, H. J. The global burden of snakebite: A literature analysis and modeling based on regional estimates of envenoming and deaths. PLoS. Med., 2008, 5, e218.
3. Warrell D. A. Snakebite. Lancet, 2010, 375, 77-88.
4. Williams, D.; Gutiérrez, J. M.; Harrison, R.; Warrell, D.A.; White, J.; Winkel, K. D.; Gopalakrishnakone, P. The global snakebite initiative: An antidote for snakebite. Lancet, 2010, 375, 89-91.
5. Harvey, A. L. Snake toxins. Pergamon press, New York, 1991.
6. Aird, S. D. Ophidian envenomation strategies and the role of purines. Toxicon, 2002, 40, 335-393.
7. Ménez, A. The subtle beast. Snakes, from myth to medicine. London: Taylor and Francis, 2003.
8. Chippaux, J. P.; Williams, V.; White, J. Snake venom variability: methods of study, results and interpretations. Toxicon, 1991, 29, 1279-1303.
9. Daltry, J. C.; Wüster, W.; Thorpe, R. S. Diet and snake venom evolution. Nature, 1996, 379, 537-540.
10. Sasa, M. Diet and snake venom variation: can local selection alone explain intraspecific venom variation? Toxicon, 1999, 37, 249-252.
11. Shashidhara Murthy, R.; Jagadeesha, D. K.; Girish, K. S.; Kemparaju, K. Variation in biochemical and pharmacological properties of Indian cobra (Naja naja) venom due to geographical distribution, Mol. Cell. Biochem., 2002, 229, 93-101.
12. Girish, K. S.; Jagadeesha, D. K.; Rajeev, K. B.; Kemparaju, K. Snake venom hyaluronidase: an evidence for isoforms and extracellular matrix degradation. Mol. Cell. Biochem., 2002, 240, 105-110.
13. Gutierrez, J. M.; Rucavado, A. Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage. Biochimie, 2000, 82, 841-850.
14. Yingprasertchai, S.; Bunyasrisawat, S.; Ratanabanangkoon, K. Hyaluronidase inhibitors (sodium cromoglycate and sodium aurothiomalate) reduce the local tissue damage and prolong the survival time of mice injected with Naja kaouthia and Calloselasma rhodostoma venoms, Toxicon, 2003, 42, 635-646.
15. Paul, V. K. Animal and insect bites. In: Singh M (Ed). Medical Emergencies in Children 2nd Ed, New Deihi, Sagar Publications, 1993.
16. Estevao-Costa, M. I.; Diniz, C. R.; Magalhaes, A.; Markland, F. S.; Sanchez, E. F. Action of metalloproteinases mytalysin I and II on several components of the Hemostatic and Fibrinolytic systems. Thrombosis Res., 2000, 99, 363-376.
17. Moura-da-Silva, A. M.; Della-Casa, M. S.; David, A. S.; Assakura, M. T.; Butera, D.; Lebrun, I.; Shannon, J. D.; Serrano, S. M. T.; Fox, J. W. Evidence for heterogeneous forms of the snake venom metalloproteinase jararahagin: a factor contributing to snake venom variability. Arch. Biochem. Biophys., 2003, 409, 395-401.
18. Kini, R. M. Venom phospholipase A2 enzymes: structure, function and mechanism. J. Wiley, New York. 1997.
19. Ownby, C. L.; Selistre de Araujo, H. S.; White, S. P.; Fletcher, J. E. Lysine 49 phospholipase A2 proteins. Toxicon, 1999, 37, 411-445.
20. Kini, R. M. Excitement ahead: Structure, function and mechanism of snake venom phospholipase A2 enzymes. Toxicon, 2003, 42, 827-840.
21. Lomonte, B.; Angulo, Y.; Calderon, L. An overview of lysine-49 phospholipase A2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action. Toxicon, 2003, 42, 885-901.
22. Soares, A. M.; Fontes, M. R. M.; Giglio, J. R. Phospholipases A2 myotoxins from Bothrops snake venoms: structure-function relationship. Curr. Org.Chem., 2004, 8, 1677-1690.
23. Burke, J. E.; Dennis, E. A. Phospholipase A2 biochemistry. Cardiovasc. Drugs. Ther., 2009, 23, 49-59.
24. Huang, H. C.; Lee, C. Y. Isolation and pharmacological properties of phospholipase A2 from Vipera russelli (Russell's viper) snake venom. Toxicon, 1984, 22, 207-217.
25. Thamaree, S.; Sitprija, V.; Leepipatpaiboon, S.; Witayalertpunya, S.; Thaworn, N. Mediators and renal hemodynamics in Russell's viper envenomation. J. Nat. Toxins., 2000, 9, 43-48.
26. Kamiguti, A. S.; Hay, C. R. M.; Theakston, R. D. G.; Zuzel, M. Insights into the mechanism of hemorrhage caused by the snake venom metalloproteinases. Toxicon., 1996, 34, 627-642.
27. Chisari, A.; Spinedi, E.; Voirol, M. J.; Giovambattista, A.; Gaillard, R. C. A phospholipase A2-related snake venom (from Crotalus durissus terrificus) stimulates neuroendocrine and immune functions determination of different sites of action. Endocrinology, 1998, 139, 617-625.
28. Garcia, L. T.; Parreiras e Silva, L. T.; Ramos, O. H.; Carmona, A. K.; Bersanetti, P. A.; Selistre-de-Arujo, H. S. The effect of posttranslational modifications on the hemorrhagic activity of snake venom metalloproteinases. Comp. Biochem. Physiol. (Part C), 2004, 138, 23-32.
29. Howes, J. M.; Kamiguti, A. S.; Theakston, R. D. G.; Wilkinson, M. C.; Laing, G. D. Effects of three novel metalloproteinases from the venom of the West African saw-scaled viper, Echis ocellatus on blood coagulation and platelets. Biochim. Biophys. Acta, 2005, 1724, 194-202.
30. Kamiguti, A. S. Platelets as targets of snake venom metalloproteinases. Toxicon, 2005, 45, 1041-1049.
31. Schattner, M.; Fritzen, M.; Ventura, J. S.; Modesto, J. C. A.; Pozner, R. G.; Moura-da-Silva, A. M.; Chudzinski-Tavassi, A. M. The snake venom metalloproteases berythractivase and jararhagin activate endothelial cells. Biol. Chem., 2005, 386, 369-374.
32. Laing, G. D.; Moura-da-Silva, A. M. Jarahagin and its multiple effects on hemostasis. Toxicon, 2005, 45, 987-996.
33. Moura-da-Silva, A. M.; Butera, D.; Tanjoni, I. Importance of snake venom metalloproteinases in cell biology: effects on platelets, inflammatory and endothelial cells. Curr. Pharm. Des., 2007, 13, 2893-2905.
34. Gutiérrez, J. M.; Lomonte, B.; León, G.; Rucavado, A.; Chaves, F.; Angulo, Y. Trends in snakebite envenomation therapy: scientific, technological and public health considerations. Curr. Pharm. Des., 2007, 13, 2935-2950.
35. Clemetson, K. J.; Lu, Q.; Clemetson, J. M. Snake venom proteins affecting platelets and their applications to anti-thrombotic research. Curr. Pharm. Des., 2007, 13, 2887-2892.
36. Reid, H. A: Venomous bites and stings. In: Black JA, Ed. Paediatric Emergencies. London; Butterworths, 1979.
37. K. S. Essentials of Forensic Medicine and Toxicology, 12th Eds, Hyderabad, Laxmi Printers, 1980.
38. Reid, H. A.; Thekaston, R. D. G. The management of snakebites. Bull WHO 63: 885-895, 1983.
39. Chaves, F.; Barboza, M.; Gutierrez, J. M. Pharmacological study of edema induced by venom of the snake Bothrops asper (terciopelo) in mice. Toxicon, 1995, 33, 31-39.
40. Noble, P. W. Hyaluronan and its catabolic products in tissue injury and repair. Matrix. Biol., 2002, 21, 25-29.
41. Teixeira, C.F.P.; Fernandes, C.M.; Zuliani, JP.; Zamuner, S.F. Inflammatory effects of snake venom metalloproteinases. Mem. Inst. Oswaldo Cruz., 2005, 100, 181-184.
42. Girish, K. S.; Kemparaju, K. The magic glue hyaluronan and its eraser hyaluronidase: A biological overview. Life Sci., 2007, 80, 1921-1943.
43. Mebs, D.; Samejima, Y. Purification from Australian elapid venoms and properties of phospholipase A2, which cause myoglobinurea in mice. Toxicon, 1980, 18, 443-454.
44. Gopalakrishnakone, P.; Hawgood, B. J.; Holbrooke, S. E.; Marsh, N. A.; Santa, De. Sa. S.; Tu, A. T. Sites of action of Mojave toxin isolated from the venom of the Mojave rattlesnake. Br. J. Pharmac., 1980, 69, 421-431.
45. Ziolkowski, C.; Bieber, A. L. Mojave toxin affects fusion of myoblasts and viability of myoblasts and viability of myotubes in cell cultures. Toxicon, 1992, 30, 733-744.
46. Rucavado, A.; Lomonte, B. Neutralization of myonecrosis, hemorrhage and edema induced by Bothrops asper snake venom by homologous and heterologous pre-existing antibodies in mice. Toxicon, 1996, 34, 567-578.
47. Gutierrez, J. M.; Lomonte, B. Phospholipase A2 myotoxins from Bothrops snake venoms. In: Kini RM Ed., Venom Phospholipase A2 Enzyme: Structure, Function and Mechanism. John Wiley and sons. England 321-352, 1997.
48. Gopalakrishnakone, P.; Ponraj, D.; Thwin, M. M. Myotoxic phospholipases from snake venoms: General myoglobinuric and local myonecrotic toxins. In: Venom phospholipase A2 enzymes: Structure, Function and Mechanism. Ed., Kini, R.M.; John Wiley & Sons Ltd. 287-319, 1997.
49. Salvini, T. F.; Amaral, A. C.; Miyabara, E. H.; Turri, J. A.; Danells, P. M.; Selistre de Araujo, H. S. Systemic skeletal muscle necrosis induced by crotoxin. Toxicon, 2001, 39, 1141-1149.
50. Doley, R.; Zhou, X.; Kini, R.M. Snake venom Phospholipase A2 enzymes, in S.P. Mackessy (Ed.), Handbook of Venoms and Toxins of Reptiles, CRC Press/ Taylor & Francis Group, Boca Raton, pp. 173-205, 2009.
51. Dziabek, M.; Paulsson, M.; Aumailley, N.; Timpl, R. Purification and tissue distribution of a small protein (BM-40) extracted from a basement membrane tumour. Eur. J. Biochem., 1986, 161, 455-464.
52. Termine, J. D.; Kleinman, H. K.; Whiteson, W. W.; Conn, K. M.; Mc Garuey, M. L.; Martin, G. R. Osteonectin, a bone specific protein linking mineral in collagen. Cells, 1981, 26, 99-105.
53. Sage, H.; Johnson, C.; Bornstein, P. Characterization of a novel serum albumin binding glycoprotein secreted by endothelial cells in culture. J. Biol. Chem., 1984, 259, 3993-4007.
54. Yarchenco, P. D.; O'Rear, J. In: Supramolecular Organization of Basement Membranes. Rohrbach, D. H.; Timpl, R. Eds., Molecular and cellular aspects of basement membranes, Academic press, San Diego, 19-47, 1993.
55. Aamailley, M.; Gayraud, M. Structure and biological activity of the extracellular matrix. J. Mol. Med., 1998, 76, 253-265.
56. Toole, B. P. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer, 2004, 4, 528-539.
57. Hite, L. A.; Jia, L.G.; Bjarnason, J. B.; Fox, J. W. cDNA sequences for four snake venom metalloproteinases: structure, classification and their relationship to mammalian reproductive proteins. Arch. Biochem. Biophys., 1994, 308, 182.
58. Bjarnason, J. B.; Fox, J. W. Hemorrhagic metalloprotease from snake venoms. Pharmacol. Ther., 1994, 62, 325-372.
59. Anai, K.; Sugiki, M.; Yoshida, E.; Maruyama, M. Neutralization of a snake venom haemorrhagic metalloproteinase prevents coagulopathy after subcutaneous injection of Bothrops jararaca venom in rats. Toxicon, 2002, 40, 63-68.
60. Watanabe, L.; Shannon, J. D.; Valente, R. H.; Rucavado, A.; Alape-Giron, A.; Kamiguti, A. S.; Theakston, R. D.; Fox, J. W.; Gutierrez, J. M.; Arni, R. K. Amino acid sequence and crystal structure of BaP1, a metalloproteinase from Bothrops asper snake venom that exerts multiple tissue-damaging activities. Protein. Sci., 2003, 12, 2273-2281.
61. Fox, J. W.; Serrano, S. M. T. Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. Toxicon, 2005, 45, 969-985.
62. Fox, J. W.; Serrano, S. M. Insights into and speculations about snake venom metalloproteinase (SVMP) synthesis, folding and disulfide bond formation and their contribution to venom complexity. FEBS J., 2008, 275, 3016-3030.
63. Fox, J. W.; Serrano, S. M. T. In: Snake Venom Metalloproteinases. Mackessy, S.P. Ed., Handbook of Venoms and Toxins of Reptiles, CRC Press/Taylor & Francis Group, Boca Raton, pp. 95-113, 2009.
64. Oliveira, A. K.; Paes Leme, A. F.; Asega, A. F.; Camargo, A. C.; Fox, J. W.; Serrano, S. M. New insights into the structural elements involved in the skin haemorrhage induced by snake venom metalloproteinases. Thromb Haemost., 2010, 104, 485-497.
65. Baramova, E. N.; Shannon, J. D.; Bjarnason, J. B.; Fox, J. W. Degradation of extracellular matrix proteins by hemorrhagic metalloproteinases. Arch. Biochem. Biophys., 1989, 275, 63-71.
66. Kalluri, R. Basement membranes: Structure, assembly and role in tumor angiogenesis. Nat. Rev. Cancer., 2003, 3, 422-433.
67. Escalante, T.; Shannon, J.; Moura-da-Silva, A. M.; Gutierrez, J. M.; Fox, J. W. Novel insights into capillary vessel basement membrane damage by snake venom hemorrhagic metalloproteinases: a biochemical and immunohistochemical study. Arch. Biochem. Biophys., 2006, 455, 144-153.
68. Lebleu, V. S.; Macdonald, B.; Kalluri, R. Structure and function of basement membrane. Exp. Biol. Med., 2007, 232, 1121-1129.
69. Maruyama, M.; Sugiki, M.; Yoshida, E.; Shimaya, K.; Mihara, H. Broad substrate specificity of snake venom fibrinolytic enzymes: possible role in hemorrhage. Toxicon, 1992, 30, 1387-1397.
70. Escalante, T.; Franceschi, A.; Rucavado, A.; Gutierrez, J. M. Effectiveness of Batimastat: a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1: a hemorrahagic metalloproteinase from the venom of Bothrops asper. Biochem. Pharmacol., 2000, 60, 269-274.
71. Johnson, E. K.; Ownby, C. L. Isolation of a hemorrhagic toxin from the venom of Agkistrodon contortrix laticinctus (broadbanded copperhead) and pathogenesis of the hemorrhage induced by the toxin in mice. Int. J. Biochem., 1993, 25, 267-278.
72. Kamiguti, A. S.; Zuzel, M.; Theakston, R. D. Snake venom metalloproteinases and disintegrins: interaction with cells. Braz. J. Med. Biol. Res., 1998, 31, 853-862.
73. Ramos, O. H.; Selistre-de-Araujo, H. S. Comparative analysis of the catalytic domain of hemorrhage and non-hemorrhagic snake venom metallopeptidases using bioinformatic tools. Toxicon, 2004, 44, 529-538.
74. Gutiérrez, A.; Rucavado, T.; In: Escalante. Snake Venom Metalloproteinases: Biological Roles and Participation in the Pathophysiological of Envenomation. Mackessy, S.P Ed., Handbook of Venoms and Toxins of Reptiles, CRC Press/ Taylor & Francis Group, Boca Raton, pp. 115-138, 2009.
75. Baldo, C.; Jamora, C.; Yamanouye, N.; Zorn,T. M.; Moura-da- Silva, A. M. Mechanism of vascular damage by hemorrhagic snake venom metalloproteinases: tissue distribution and in situ hydrolysis. PLOS. Negl. Trop. Dis., 2010, 29, e727.
76. Gallagher, P.; Bao, Y.; Serrano, S. M.; Liang, G. D.; Theakston, R. D.; Gutierrez, J. M.; Escalante, T.; Zigrino, P.; Moura-da-Silva, A. M.; Nischt, R.; Mauch, C.; Moskaluk, C.; Fox, J. W. Role of the snake venom toxin jarahagin in proinfllmatory pathogenesis: in vitro and in vivo gene expression analysis of the effects of the toxin. Arch. Biochem. Biophys., 2005, 441, 1-15.
77. Pinto, A. F.; Ma, L.; Dragulev, B.; Guimaraes, J. A.; Fox, J. W. Use of SILAC for exploring sheddase and matrix degradation of fibroblasts in culture by the PIII SVMP atrolysin A: Identification of two novel substrates with functional relevance. Arch. Biochem. Biophys., 2007, 465, 11-15.
78. Menzel, E. J.; Farr, C. Hyaluronidases and its substrate: biochemistry, biological activities and therapeutic uses. Cancer Lett., 1998, 131, 3-11.
79. Shimizu, M. T.; Jorge, A. O. C.; Unterkircher, C. S.; Fantinanto, V.; Paula, C. R. Hyaluronidase and chondroitin sulphatase production by different species of Candida. J. Med. Vet. Mycology., 1995, 33, 27-31.
80. Frost, G. I.; Tony, C.; Stern, R. The hyaluronidases: a chemical, biological and clinical overview. Trends. Glycosc. Glycotechnol., 1996, 8, 419-434.
81. Stern, R.; Jedrzejas, M. J. Hyaluronidases: Their genomics, structures, and mechanisms of action. Chem. Rev., 2006, 106, 818-839.
82. G. Hyaluronidases-a group of neglected enzymes. Protein. Sci., 1995, 4, 1666-1669.
83. Girish, K. S.; Shashidharamurthy, R.; Nagaraju, S.; Gowda, T. V.; Kemparaju, K. Isolation and characterization of hyaluronidase a 'spreading factor' from Indian cobra (Naja naja) venom. Biochimie, 2004a, 86, 193-202.
84. Girish, K. S.; Kemparaku, K. A low molecular weight isoform of hyaluronidase: purification from Indian Cobra (Naja naja) venom and partial characterization. Biochemistry (Mos), 2005a, 70, 708-712.
85. Nagaraju, S.; Mahadeshwara swamy, Y. H.; Girish, K. S.; Kemparaju, K. Venom from spiders of the genus Hippasa: Biochemical and pharmacological studies. Comp. Biochem. Physiol., 2006,144, 1-9.
86. Nagaraju, S.; Devaraja, S.; Kemparaju, K. Purification and properties of hyaluronidase from Hippasa partita (funnel web spider) venom gland extract. Toxicon, 2007, 50, 383-393.
87. Kemparaju, K.; Girish, K. S. Snake venom hyaluronidase: a therapeutic target. Cell. Biochem. Funct., 2006, 24, 7-12.
88. Meyer K. In: Hyaluronidases. Enzymes. Boyer, P.D. Ed, New York; Academic Press, 307-320, 1971.
89. Baker, J. R.; Dong, S.; Pritchard, D. G. The hyaluronan lyase of Streptococcus pyogenes bacteriophage H4489A. Biochem. J., 2002, 365, 317-322.
90. Saitoh, H.; Takagaki, K.; Majima, M.; Nakamura, T.; Matsuki, A.; Kasai, M.; Narita, H.; Endo, M. Enzymatic reconstruction of glycosaminoglycan oligosaccharide chains using the transglycosylation reaction of bovine testicular hyaluronidase. J. Biol. Chem., 1995, 270, 3741-3747.
91. Laurent, T. C.; Fraser, J. R. E. Hyaluronan. FASEB Journal., 1992, 6, 2397-2404.
92. Girish, K. S.; Kemparaju, K. Inhibition of Naja naja venom hyaluronidase: role in the management of poisonous bite. Life Sci., 2006, 78, 1433-1440.
93. Angulo, Y.; Lomonte, B. Inhibitory effect of fucoidan on the activities of crotaline snake venom myotoxic phospholipases A2. Biochem. Pharmacol., 2003, 66, 1993-2000.
94. Pithayanukul, P.; Leanpolcharenchai, J.; Saparpakorn, P. Molecular docking studies and anti-snake venom metalloproteinase activity of Thai mango seed kernel extract. Molecules, 2009, 14, 3198-3213.
95. Zhang, D.; Botos, I.; Gomis-Ruth, F.X.; Doll, R.; Blood, C.; Njoroge, F.G.; Fox, J.W.; Bode, W.; Meyer, E.F. Structural interaction of natural and synthetic inhibitors with the venom metalloproteinase, atrolysin C (form d). Proc. Natl. Acad. Sci. USA, 1994, 91, 8447-8451.
96. Soares, A. M.; Ticli, F. K.; Marcussi, S.; Lourenço, M. V.; Januário, A. H.; Sampaio, S. V.; Giglio, J. R.; Lomonte, B.; Pereira, P. S. Medicinal plants with inhibitory properties against snake venoms. Curr. Med. Chem., 2005, 12, 2625-2641.
97. Marcussi, S.; Sant'Ana, C. D.; Oliveira, C. Z.; Rueda, A. Q.; Menaldo, D. L.; Beleboni, R. O.; Stabeli, R. G.; Giglio, J. R.; Fontes, M. R.; Soares, A. M. Snake venom phospholipase A2 inhibitors: medicinal chemistry and therapeutic potential. Curr. Top. Med. Chem., 2007, 7, 743-756.
98. Rucavado, A.; Henriquez, M.; Garcia, J.; Gutierrez, J. M. Assessment of metalloproteinase inhibitors clodronate and doxycycline in the neutralization of hemorrhage and coagulopathy induced by Bothrops asper snake venom. Toxicon, 2008, 52, 754-759.
99. Girish, K.; Kemparaju, S.; Nagaraju, B. S; Vishwanath. Hyaluronidase inhibitors: a biological and therapeutic perspective. Curr Med Chem., 2009, 16, 2261-2288.
100. Girish, K. S. Kemparaju, K. Inhibition of Naja naja venom hyaluronidase by plant derived bioactive components and polysaccharides. Biochemistry, 2005b, 70, 1145-1150.
101. Sánchez, E. E.; Rodríguez-Acosta, A. Inhibitors of Snake Venoms and Development of New Therapeutics. Immunopharmacol. Immunotoxicol., 2008, 30, 647-678.
102. Gomes, A.; Das, R.; Sarkhel, S.; Mishra, R.; Mukherjee, S.; Bhattacharya, S.; Gomes, A. Herbs and herbal constituents active against snakebite. Ind. J. Expt. Biol., 2010, 48, 865-878.
103. Lomonte, B.; Leon, G.; Hanson, L. A. Similar effectiveness of Fab and F(ab')2 anti-venoms in neutralization of hemorrhagic activity of Vipera berus snake venom in mice. Toxicon, 1996, 34, 1197-1202.
104. León, G.; Rojas, G.; Lomonte, B.; Gutiérrez, J. M. IgG and F(ab')2 polyvalent anti-venoms do not differ in their ability to neutralize hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom. Toxicon, 1997,35, 1627-1633.
105. Leon, G.; Valverde, J. M.; Rojas, G.; Lomonte, B.; Gutierrez, J. M. Comparative study on the ability of IgG and Fab sheep anti-venoms to neutralize local hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom. Toxicon, 2000, 38, 233-244.
106. Calmette, A. Límmunisation artificelle des animaux contre le venin des serpents et la therapeutic experimentale de morsures venimeuses. CR Soc. Biol., 1894, 46: 120-124.
107. Guidlolin, R. G.; Marcelino, R. M.; Gondo, H. H.; Morais, J. F.; Ferreira, R. A.; Silva, C. L.; Kipnis, T. L.; Silva, J. A.; Fafetine, J.; da Silva, W. D. Polyvalent horse F(Ab')2 snake anti-venom: development of process to produce polyvalent horse F(Ab')2 antibodies anti-african snake venom. Afric. J. Biotechnol., 2010, 9, 2446-2455.
108. Landon, J.; Smith, D. C. In: Development of Novel Anti-Venoms Based on Specific Ovine Fab. Bon, C., Goyffon, M. Eds., Envenomings and Their Treatments. Editions Foundation Marcel Merieux, Lyon, pp. 173-180, 1996.
109. Theakston, R. D. G. Clinical features of envenoming from snakebites. In: Bon C and Goyffon M (eds). Envenomings and their treatments. Fondation Marcel Merrieux., 1996, 117-126.
110. Karlson-Stiber, C.; Presson, H.; Smith, D.; Al-abdulla, I. H.; Sjostrom, L. First clinical experiences with specific sheep Fab fragments in snakebite. Report of a multicentre study of Vipera berus envenoming. J. Intern. Med., 1997, 241, 53-58.
111. Theakston, R. G. D.; Warrell, D. A.; Griffiths, E. Report of a WHO workshop on the standardization and control of anti-venoms. Toxicon, 2003, 41, 541-557.
112. Gutiérrez, J. M.; Rojas, E.; Quesada, L.; León, G.; Núñez, J.; Laing, G. D.; Sasa, M.; Renjifo, J. M.; Nasidi, A.; Warrell, D. A.; Theakston, R. D.; Rojas, G. Pan-African polyspecific anti-venom produced by capryic acid purification of horse IgG: An alternative to the anti-venom crisis in Africa. Trans R Soc. Trop. Med. Hyg., 2005, 99, 468-475.
113. Rojas, G.; Jimenez, J. M.; Gutierrez, J. M. Caprylic acid fraction of hyperimmune horse plasma: Description of a simple procedure for anti-venom production. Toxicon, 1994, 32, 351-363.
114. Lalloo, D.; Theakston, R. D. G. Snake anti-venoms. J. Toxicol. Clin. Toxicol., 2003, 41, 277-290.
115. Theakston, R. D.; Warrell, D. A. Confronting the neglected problem of snakebite envenoming: the need for a global partnership. PloS. Med., 2006, 3, e150.
116. Scherrmann, J. M. Antibody treatment of toxic poisoning, recent advances. Clin. Toxicol., 1994, 32, 363-375.
117. Riviere, G.; Choumet, V.; Audebert, F.; Sabouraud, A.; Debray, M.; Scherrmann, J. M.; Bon, C. Effect of anti-venom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of anti-venom therapy. J. Pharmacol. Exp. Ther., 1997, 281, 1-8.
118. Leon, G.; Rojas, G.; Lomonte, B.; Gutierrez, J. M. Immunoglobulin G and F(ab)2 polyvalent anti-venoms do not differ in their ability to neutralize hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom. Toxicon, 1997, 35, 1627-1637.
119. Abdel-Latif, S. S., Wanas, S., Malak, G. A., Helmy, M. H. Efficacy of IgG, Fab, and F(ab') 2 fragments of horse anti-venom in the treatment of local symptoms after Cerastes cerastes (Egyptian snake) bite. Afr. J. Biotechnol., 2003, 2, 189-193.
120. Martz, W. Plants with a reputation against snakebite. Toxicon, 1992, 30, 1131-1142.
121. Mors, W. B.; Nascimento, M. C.; Pereira, B. M.; Pereira, N. A. Plant natural products active against snakebite the molecular approach. Phytochemistry, 2000, 55, 627-642.
122. Girish, K. S.; Mohanakumari, H. P.; Nagaraju, S.; Vishwanath, B. S.; Kemparaju, K. Hyaluronidase and protease activity from Indian snake venoms: Neutralization by Mimosa pudica root extract. Fitoterapia, 2004b, 75, 378-380.
123. Gomes, A.; Saha, A.; Chatterjee, I.; Chakravarty, A. K. Viper and cobra venom neutralization by b-sitosterol and stigmasterol isolated from the root extract of Pluchea indica Less. (Asteraceae). Phytomed, 2007, 14, 637-643.
124. Ushanandini, S.; Nagaraju, S.; Harish Kumar, K., Vedavathi, M.; Machiah, D. K.; Kemparaju. K.; Vishwanath, B. S.; Gowda, T. V.; Girish, K. S. The antisnake venom properties of Tamarindus indica (Leguminosae) seed extract. Phytother. Res., 2006, 20, 851-858.
125. Borges, M. H.; Alves, D. L. F.; Raslan, D. S., Piló-Veloso, D.; Rodrigues, V. M.; Homsi-Brandeburgo, M. I.; de Lima, M. E. Neutralizing properties of Musa paradisiaca L (Musaceae) juice on Phospholipase A2, myotoxic, hemorrhagic and lethal activities of crotalidae venoms. J. Ethnopharmacol., 2005, 98, 21-29.
126. Cavalcante, W. L. G.; Campos, T. O.; Pai-Silva, M. D., Pereira, P. S.; Oliveira, C. Z.; Soares, A. M.; Gallacci, M. Neutralization of snake venom phospholipase A2 toxins by aqueous extract of Casearia sylvestris (Flacourtiaceae) in mouse neuromuscular preparation. J. Ethnopharmacol., 2007, 112, 490-497.
127. Omori-Satoh, T.; Sadahiro, S.; Ohsaka, A.; Murata, R. Purification and characterization of an antihemorrhagic factor in the serum of Trimeresurus flavoviridis, a crotalid. Biochim.Biophys. Acta., 1972, 285, 414-426.
128. Yamakawa, Y.; Omori-Satoh, T. Primary structure of the antihemorrhagic factor in serum of the Japanese Habu: a snake venom metalloproteinase inhibitor with a double headed cystatin domain. J. Biochem., 1992, 112, 583-589.
129. Deshimaru, M.; Tanaka, C.; Fujino, K.; Aoki, N.; Terada, S.; Hattori, S.; Ohno, M. Properties and cDNA cloning of an antihemorrhagic factor (HSF) pirified from the serum of Trimeresurus flavoviridis. Toxicon, 2005, 46, 937-945.
130. Aoki, N.; Deshimaru, M.; Terada, S. Active fragments of the antihemorrhagic protein HSF from serum of habu (Trimeresurus flavoviridis). Toxicon, 2007, 49, 653-662.
131. Neves-Ferreira, A. C.; Valente, R. H.; Perales, J.; Domont, G. B. Natural inhibitors Innate immunity to snake venoms. A book chapter in handbook of Venoms and Toxins of Reptiles edited by Stephen P Mackessy, CRC Press, PP 259-284, 2009.
132. Bode, W.; Fernandez-Catalan, C.; Tschesche, H.; Grams, F.; Nagase, H.; Maskos, K. Structural properties of matrix metalloproteinases. Cell. Mol. Life. Sci., 1999, 55 (4), 639-652.
133. Soto, J. G.; Perez, J. C.; Minton, S. A. Proteolytic, hemorrhagic and hemolytic activities of snake venoms. Toxicon, 1988, 26, 875-882.
134. J. C.; Sánchez, E. E. Natural protease inhibitors to hemorrhagins in snake venoms and their potential use in medicine. Toxicon, 1999, 37, 703-728.
135. Fortes-Dias, C. L. Endogenous inhibitors of snake venom phospholipases A2 in the blood plasma of snakes. Toxicon, 2002, 40, 481-484.
136. Ohkura, N.; Ohkura, H.; Inoue, S.; Ikeda, K.; Hayashi, K. Purification and characterization of threedistinct types of Phospholipase A2 inhibitors from the blood plasma of the Chinese mamushi, Agkistrodon blomhoffii siniticus. Biochem. J., 1997, 325, 527-531.
137. Lizano, S.; Domont, G. B.; Perales, J. Natural Phospholipase A(2) myotoxin inhibitor proteins from snakes, mammals and plants. Toxicon, 2003, 42, 963-977.
138. Rocha, S. L.; Lomonte, B.; Neves-Ferreira, A. G. C.; Trugilho, M. R. O.; Junqueira-de-Azevedo, I. L.; Ho, P. L.; Domont, G. B.; Gutierrez, J. M.; Perales, J. Functional analysis of DM64, an antimyotoxic protein with immunoglobulin-like structure from Didelphis marsupialis serum. Eur. J. Biochem., 2002, 269, 6052-6062.
139. Quiros, S.; Alape-Giron, A.; Angulo, Y.; Lomonte, B. Isolation, characterization and molecular cloning of AnMIP, a new alphatype Phospholipase A2 myotoxin inhibitor from the plasma of the snake Atropoides nummifer (Viperidae: Crotalinae). Comp. Biochem. Physiol. B, 2007, 146, 60-68.
140. Perales, J.; Villela, C.; Domont, G. B.; Choumet, V.; Saliou, B.; Moussatche, H.; Bon, C.; Faure, G. Molecular structure and mechanism of action of the crotoxin inhibitor from Crotalus durissus terrificus serum. Eur. J. Biochem., 1995, 227, 19-26.
141. Santos-Filho, N.A.; Fernabdes, C.A.; Menaldo, D.L.; Magro, A.J.; Fortes-Dias, C.L.; Estevao-Costa, M.I.; Fontes, M.R.; Santos, C.R.; Murakami, M.T.; Soares, A.M. Molecular cloning and biochemical characterization of a myotoxin inhibitor from Bothrops alternatus snake plasma. Biochimie, 2010, 93(3),583-592.
142. Ovadia, M.; Kochva, E. Neutralization of viperidae and elapidae snake venoms by sera of different animals. Toxicon, 1977, 15, 541-547.
143. Satish Kumar, M.; Nanjunda Swamy, S.; Mahendra, M.; Shashidhara Prasad, J; Viswanath, B.S.; Rangappa, K.S. Novel delta2-isoxazolines as group II phospholipase A2 inhibitors. Bioorg. Med. Chem. Lett., 2004, 14, 3679-3681.
144. Murari, S.K.; Sriharsha, S.N.; Shashikanth, S.; Vishwanath, B.S. Synthesis of benzophenone oxime analogues as inhibitor of secretory phospholipase A(2) with anti-inflammatory activity. Bioorg. Med. Chem. Lett., 2004, 14, 2423-2425.
145. Khanum, S.A.; Murari, S.K.; Vishwanth, B.S.; Shashikanth, S. Synthesis of benzoyl phenyl benzoates as effective inhibitors for phospholipase A2 and hyaluronidase enzymes. Bioorg. Med. Chem. Lett., 2005, 15, 4100-4104.
146. Sadashiva, M.P.; Nataraju, A.; Mallesha, H.; Rajesh, R.; Vishwanath, B.S.; Rangappa, K.S. Synthesis and evaluation of trimethoxyphenyl isoxazolidines as inhibitors of secretory phospholipase A2 with anti-inflammatory activity. Int. J. Mol. Med., 2005, 16, 895-904.
147. Thimmegowda, N.R.; Dharmappa, K.K.; Kumar, C.S.; Sadashiva, M.P.; Sathish, A.D.; Nanda, B.L.; Vishwanath, B.S.; Rangappa, K.S. Synthesis and evaluation of tricyclic dipyrido diazepinone derivatives as inhibitors of secretory phospholipase A2 with antiinflammatory activity. Curr. Top. Med. Chem., 2007, 7, 811-820.
148. Yerigeri, M.C.; Murari, S.K.; Thimmaiah, K.N.; Math, S.K.; Vishwanath, B.S. Anti-tubercular and anti-inflammatory activities of azetidin-2-one derivatives and their effects on the activity of Phospholipase A2. Med. Chem., 2008, 4, 190-193.
149. Campos, V.R.; Abreu, P.A.; Castro, H.C.; Rodrigues, C.R.; Jordão, A.K.; Ferreira, V.F.; de Souza, M.C.; Santos Fda, C.; Moura, L.A.; Domingos, T.S.; Carvalho, C.; Sanchez, E.F.; Fuly, A.L.; Cunha, A.C. Synthesis, biological, and theoretical evaluations of new 1,2,3-triazoles against the hemolytic profile of the Lachesis muta snake venom. Bioorg. Med. Chem., 2009, 17, 7429-7434.
150. Rucavado, A.; Escalante, T.; Franceschi, A.; Chaves, F.; León, G.; Cury, Y.; Ovadia, M.; Gutiérrez, J. M. Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA. Am. J. Trop. Med. Hyg., 2002, 63, 313-319.
151. Kemparaju, K.; Girish, K.S.; Nagaraju, S. In: Hyaluronidases, Neglected Class of Glycosidases from Snake Venom: Beyond a Spreading Factor. Mackessy, S.P. Ed., Handbook of Venoms and Toxins of Reptiles, CRC Press/ Taylor & Francis Group, Boca Raton, pp. 237-258, 2009.
152. Warrell, D.A.; Phillips, R.E.; Tin-Nu-Swe.; Tun-Pe.; Maung-Maung-Lay. Bites by Russell's viper (Vipera russelli siamensis) in Burma: haemostatic, vascular, and renal disturbances and response to treatment. Lancet, 1985, 2, 1259-1264.
153. Proby, C.; Tha-Aung.; Thet-Win.; Hla-Mon.; Burrin, J.M.; Joplin, G.F. Immediate and long-term effects on hormone levels following bites by the Burmese Russell's viper. Q. J. Med., 1990, 75, 399-411.
154. Gawarammana, I.; Mendis, S.; Jeganathan, K. Acute ischemic strokes due to bites by Daboia russelii in Sri Lanka - first authenticated case series. Toxicon, 2009, 54, 421-428.
155. Kumar, J.R.; Basavarajappa, B.S.; Arancio, O.; Aranha, I.; Gangadhara, N.S.; Yajurvedi, H.N.; Gowda, T.V. Isolation and characterization of Reprotoxin, a novel protein complex from Daboia russelii snake venom. Biochimie, 2008, 90, 1545-1559.
156. Avila-Aguero, M.L.; Valverde, K.; Gutierrez, J.M.; Paris, M.; Faingezicht, I. Venomous snakebites in children and adolescents: A 12 year retrospective review. J. Venom. Anim. Toxins, 2001, 7, 69-84.
157. Saravia-Otten, P. Studies on fibronectin binding proteins, proteases, and virulence in Staphylococcus aureus. PhD thesis, 2004, Karolinska Institutet, Stockholm, Sweden.
158. Gutierrez, J. M.; Sasa, M. Bites and envenomations by colubrid snakes in Mexico and Central America. J. Toxicol. Toxin Rev., 2002, 21, 105-115.